CYP24A1 and neoplasm: All the tested compounds had no affinity for the common off-target hCA I isoform (Ki >100 μM) and some of them were more active against the tumour-related isoform hCA IX if compared with the parent drug 2-(benzylsulfinyl)benzoic acid (Table 1).